Literature DB >> 23092172

Human embryonic stem cell-derived mesenchymal stem cell seeding on calcium phosphate cement-chitosan-RGD scaffold for bone repair.

Wenchuan Chen1, Hongzhi Zhou, Michael D Weir, Minghui Tang, Chongyun Bao, Hockin H K Xu.   

Abstract

Calcium phosphate cement (CPC) has in situ-setting ability and excellent osteoconductivity. Human embryonic stem cells (hESCs) are exciting for regenerative medicine due to their strong proliferative ability and multilineage differentiation capability. However, there has been no report on hESC seeding with CPC. The objectives of this study were to obtain hESC-derived mesenchymal stem cells (hESCd-MSCs), and to investigate hESCd-MSC proliferation and osteogenic differentiation on novel CPC with chitosan immobilized with RGD (CPC-chitosan-RGD). RGD was covalently bonded with chitosan, which was then incorporated into CPC. The CPC-chitosan-RGD scaffold had higher strength and toughness than CPC-chitosan control without RGD (p<0.05). hESCs were cultured to form embryoid bodies (EBs), and the MSCs were then migrated out of the EBs. Flow cytometry indicated that the hESCd-MSCs expressed typical surface antigen profile of MSCs. hESCd-MSCs had good viability when seeded on CPC scaffolds. The percentage of live cells and the cell density were significantly higher on CPC-chitosan-RGD than CPC-chitosan control. Scanning electron microscope examination showed hESCd-MSCs with a healthy spreading morphology adherent to CPC. hESCd-MSCs expressed high levels of osteogenic markers, including alkaline phosphatase, osteocalcin, collagen I, and Runx2. The mineral synthesis by the hESCd-MSCs on the CPC-chitosan-RGD scaffold was twice that for CPC-chitosan control. In conclusion, hESCs were successfully seeded on CPC scaffolds for bone tissue engineering. The hESCd-MSCs had good viability and osteogenic differentiation on the novel CPC-chitosan-RGD scaffold. RGD incorporation improved the strength and toughness of CPC, and greatly enhanced the hESCd-MSC attachment, proliferation, and bone mineral synthesis. Therefore, the hESCd-MSC-seeded CPC-chitosan-RGD construct is promising to improve bone regeneration in orthopedic and craniofacial applications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23092172      PMCID: PMC3589899          DOI: 10.1089/ten.TEA.2012.0172

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  64 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Biomaterials and scaffolds in reparative medicine.

Authors:  Elliot L Chaikof; Howard Matthew; Joachim Kohn; Antonios G Mikos; Glenn D Prestwich; Christopher M Yip
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

3.  Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells.

Authors:  Karin Stenderup; Jeannette Justesen; Christian Clausen; Moustapha Kassem
Journal:  Bone       Date:  2003-12       Impact factor: 4.398

4.  Effect of the particle size on the micro and nanostructural features of a calcium phosphate cement: a kinetic analysis.

Authors:  M P Ginebra; F C M Driessens; J A Planell
Journal:  Biomaterials       Date:  2004-08       Impact factor: 12.479

5.  Stromal cell activity in bone marrow from the tibia and iliac crest of patients with rheumatoid arthritis.

Authors:  Y Suzuki; K J Kim; S Kotake; T Itoh
Journal:  J Bone Miner Metab       Date:  2001       Impact factor: 2.626

6.  Relation between cell density and the secretion of von Willebrand factor and prostacyclin by human umbilical vein endothelial cells.

Authors:  M J Wissink; R Beernink; A A Poot; G H Engbers; T Beugeling; W G van Aken; J Feijen
Journal:  Biomaterials       Date:  2001-08       Impact factor: 12.479

Review 7.  Tissue engineering: orthopedic applications.

Authors:  C T Laurencin; A M Ambrosio; M D Borden; J A Cooper
Journal:  Annu Rev Biomed Eng       Date:  1999       Impact factor: 9.590

8.  HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.

Authors:  Katarina Le Blanc; Charlotte Tammik; Kerstin Rosendahl; Eva Zetterberg; Olle Ringdén
Journal:  Exp Hematol       Date:  2003-10       Impact factor: 3.084

9.  Fast-setting calcium phosphate scaffolds with tailored macropore formation rates for bone regeneration.

Authors:  Hockin H K Xu; Shozo Takagi; Janet B Quinn; Laurence C Chow
Journal:  J Biomed Mater Res A       Date:  2004-03-15       Impact factor: 4.396

Review 10.  Adult mesenchymal stem cells and cell-based tissue engineering.

Authors:  Rocky S Tuan; Genevieve Boland; Richard Tuli
Journal:  Arthritis Res Ther       Date:  2002-12-11       Impact factor: 5.156

View more
  23 in total

Review 1.  Stem Cells in Skeletal Tissue Engineering: Technologies and Models.

Authors:  Mark T Langhans; Shuting Yu; Rocky S Tuan
Journal:  Curr Stem Cell Res Ther       Date:  2016       Impact factor: 3.828

Review 2.  The current state of scaffolds for musculoskeletal regenerative applications.

Authors:  Benjamin D Smith; Daniel A Grande
Journal:  Nat Rev Rheumatol       Date:  2015-03-17       Impact factor: 20.543

3.  Restoration of bone defects using modified heterogeneous deproteinized bone seeded with bone marrow mesenchymal stem cells.

Authors:  Jun Li; Zeyu Huang; Liyan Chen; Xin Tang; Yue Fang; Lei Liu
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

4.  Angiogenic and osteogenic regeneration in rats via calcium phosphate scaffold and endothelial cell co-culture with human bone marrow mesenchymal stem cells (MSCs), human umbilical cord MSCs, human induced pluripotent stem cell-derived MSCs and human embryonic stem cell-derived MSCs.

Authors:  Wenchuan Chen; Xian Liu; Qianmin Chen; Chongyun Bao; Liang Zhao; Zhimin Zhu; Hockin H K Xu
Journal:  J Tissue Eng Regen Med       Date:  2017-06-13       Impact factor: 3.963

5.  Umbilical cord and bone marrow mesenchymal stem cell seeding on macroporous calcium phosphate for bone regeneration in rat cranial defects.

Authors:  Wenchuan Chen; Jun Liu; Navid Manuchehrabadi; Michael D Weir; Zhimin Zhu; Hockin H K Xu
Journal:  Biomaterials       Date:  2013-09-18       Impact factor: 12.479

Review 6.  Stem Cells and Calcium Phosphate Cement Scaffolds for Bone Regeneration.

Authors:  P Wang; L Zhao; W Chen; X Liu; M D Weir; H H K Xu
Journal:  J Dent Res       Date:  2014-05-05       Impact factor: 6.116

7.  Reprogramming of mesenchymal stem cells derived from iPSCs seeded on biofunctionalized calcium phosphate scaffold for bone engineering.

Authors:  Jun Liu; Wenchuan Chen; Zhihe Zhao; Hockin H K Xu
Journal:  Biomaterials       Date:  2013-07-24       Impact factor: 12.479

8.  Minipig-BMSCs Combined with a Self-Setting Calcium Phosphate Paste for Bone Tissue Engineering.

Authors:  Gengtao Qiu; Ping Wang; Guangjun Li; Zhanjun Shi; Michael D Weir; Jinyu Sun; Yang Song; Jixing Wang; Huakun H Xu; Liang Zhao
Journal:  Mol Biotechnol       Date:  2016-11       Impact factor: 2.695

9.  Prevascularization of biofunctional calcium phosphate cement for dental and craniofacial repairs.

Authors:  Wenchuan Chen; WahWah Thein-Han; Michael D Weir; Qianming Chen; Hockin H K Xu
Journal:  Dent Mater       Date:  2014-05       Impact factor: 5.304

10.  Human embryonic stem cells and macroporous calcium phosphate construct for bone regeneration in cranial defects in rats.

Authors:  Xian Liu; Ping Wang; Wenchuan Chen; Michael D Weir; Chongyun Bao; Hockin H K Xu
Journal:  Acta Biomater       Date:  2014-06-24       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.